In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

被引：0
|
作者：
Mohammad Haghighi
Leila Jahangard
Hamid Mohammad-Beigi
Hafez Bajoghli
Hassan Hafezian
Alireza Rahimi
Hamid Afshar
Edith Holsboer-Trachsler
Serge Brand
机构：
[1] Hamadan University of Medical Sciences,Research Center for Behavioral Disorders and Substances Abuse
[2] Isfahan University of Medical Sciences,Isfahan Psychosomatic Research Center
[3] Tehran University of Medical Sciences,Psychiatry and Psychology Research Center (PPRC), Roozbeh Hospital
[4] Psychiatric Hospital of the University of Basel,Center for Affective, Stress and Sleep Disorders (ZASS)
来源：
Psychopharmacology | 2013年 / 228卷
关键词：
Obsessive–compulsive disorder; Memantine; SSRIs; Double-blind trial; Placebo; Y-BOCS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 640
页数：7
相关论文
共 50 条
  • [1] In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)
    Haghighi, Mohammad
    Jahangard, Leila
    Mohammad-Beigi, Hamid
    Bajoghli, Hafez
    Hafezian, Hassan
    Rahimi, Alireza
    Afshar, Hamid
    Holsboer-Trachsler, Edith
    Brand, Serge
    PSYCHOPHARMACOLOGY, 2013, 228 (04) : 633 - 640
  • [2] Memantine for Refractory Obsessive-Compulsive Disorder: Protocol for a Pragmatic, Double-blind, Randomized, Parallel-Group, Placebo-Controlled, Monocenter Trial
    Maraone, Annalisa
    Trebbastoni, Alessandro
    Di Vita, Antonella
    D'Antonio, Fabrizia
    De Lena, Carlo
    Pasquini, Massimo
    JMIR RESEARCH PROTOCOLS, 2023, 12
  • [3] Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
    Afshar, Hamid
    Akuchekian, Shahla
    Mahaky, Behzad
    Zarean, Elham
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (10): : 976 - 981
  • [4] Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Sahraian, Ali
    Jahromi, Leila Razeghian
    Ghanizadeh, Ahmad
    Mowla, Arash
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (02) : 246 - 249
  • [5] Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial
    Hasan Mirzazadeh
    Younes Ghaeminia
    Amin Mohamad Niaei
    Mohammadsadegh Kamran
    Leila Razeghian Jahromi
    Reza Moshfeghinia
    BMC Psychiatry, 25 (1)
  • [6] Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study
    Ghaleiha, Ali
    Entezari, Neda
    Modabbernia, Amirhossein
    Najand, Babak
    Askari, Neda
    Tabrizi, Mina
    Ashrafi, Mandana
    Hajiaghaee, Reza
    Akhondzadeh, Shahin
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (02) : 175 - 180
  • [7] Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial
    Sanaz Askari
    Saba Mokhtari
    Seyed Vahid Shariat
    Behnam Shariati
    Masoomeh Yarahmadi
    Mohammadreza Shalbafan
    BMC Psychiatry, 22
  • [8] Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial
    Farnia, Vahid
    Gharehbaghi, Haniyeh
    Alikhani, Mostafa
    Almasi, Afshin
    Golshani, Sanobar
    Tatari, Faeze
    Davarinejad, Omran
    Salemi, Safora
    Bahmani, Dena Sadeghi
    Holsboer-Trachsler, Edith
    Brand, Serge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 137 - 143
  • [9] N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial
    Afshar, Hamid
    Roohafza, Hamidreza
    Mohammad-Beigi, Hamid
    Haghighi, Mohammad
    Jahangard, Leila
    Shokouh, Pedram
    Sadeghi, Masoumeh
    Hafezian, Hasan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (06) : 797 - 803
  • [10] Buprenorphine augmentation improved symptoms of OCD, compared to placebo - Results from a randomized, double-blind and placebo-controlled clinical trial
    Ahmadpanah, Mohammad
    Reihani, Amin
    Ghaleiha, Ali
    Soltanian, Alireza
    Haghighi, Mohammad
    Jahangard, Leila
    Bahmani, Dena Sadeghi
    Holsboer-Trachsler, Edith
    Brand, Serge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 : 23 - 28
12345